The rise of domestic biopharmaceutical startups across Japan, South Korea, China, and Australia is generating strong demand for early-stage CRO services. Detailed analysis within the Asia Pacific CRO Market report demonstrates that local biotech innovation ecosystems rely heavily on regional CROs for preclinical lead optimization, toxicology studies, and Phase I clinical trial design....